Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB
Open Access
- 1 May 2003
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 44 (5) , 943-952
- https://doi.org/10.1194/jlr.m200482-jlr200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Liver Receptor Homologue-1 Mediates Species- and Cell Line-specific Bile Acid-dependent Negative Feedback Regulation of the Apical Sodium-dependent Bile Acid TransporterPublished by Elsevier ,2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- 1-[4-[4[(4 R,5 R)-3,3-Dibutyl-7-(dimethylamino)-2,3,4,5-tetrahydro-4-hydroxy-1,1-dioxido-1-benzothiepin-5-yl]phenoxy]butyl]-4-aza-1-azoniabicyclo[2.2.2]octane Methanesulfonate (SC-435), an Ileal Apical Sodium-Codependent Bile Acid Transporter Inhibitor Alters Hepatic Cholesterol Metabolism and Lowers Plasma Low-Density Lipoprotein-Cholesterol Concentrations in Guinea PigsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- The Magnitude of Decrease in Hepatic Very Low Density Lipoprotein Apolipoprotein B Secretion Is Determined by the Extent of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition in Miniature PigsEndocrinology, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liverHepatology, 1997
- Inhibition of HMG-CoA Reductase by Atorvastatin Decreases Both VLDL and LDL Apolipoprotein B Production in Miniature PigsArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- S-8921, an ileal Na+/bile acid cotransporter inhibitor decreases serum cholesterol in hamstersLife Sciences, 1997
- Bile acid transport systems as pharmaceutical targetsEuropean Journal of Clinical Investigation, 1996
- The biology of HMG-CoA reductase: the pros of contra-regulationTrends in Biochemical Sciences, 1996